inotersen

CHEBI:CHEBI_749404

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Inotersen
rxcui
2099323
pharm_class
Antisense [CS]
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_start_date
20181005
active_ingredient_strength
284 mg/1.5mL
package_marketing_start_date
20181005
brand_name
Tegsedi
brand_name_base
Tegsedi
product_ndc
70251-915
application_number
NDA211172
labeler_name
Nitto Denko Avecia
manufacturer_name
Akcea Therapeutics, Inc.
spl_id
1e2a8082-c99c-43a0-e063-6294a90a5872
active_ingredient_name
INOTERSEN
package_ndc
70251-915-04
package_description
4000 g in 1 CONTAINER (70251-915-04)
unii
950736UC77
spl_set_id
8513207e-b55f-417b-9473-af785146a543
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class